논문KCI 등재
Global inequality in the burden of hepatitis B from 1990 to 2021: Findings from the global burden of disease study 2021: Letter to the editor on “Comprehensive approach to controlling chronic hepatitis B in China”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (9)
관련 논문AI추천
Elimination of viral hepatitis: How far are we?: Editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”Eun Ju Cho대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Comprehensive approach to controlling chronic hepatitis B in ChinaJidong Jia, Shan Shan, Xinyan Zhao대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제2호Correspondence to editorial on “Core indicators related to the elimination of hepatitis B and C virus infection in South Korea: A nationwide study”Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Expanding treatment eligibility for chronic hepatitis B: Balancing benefits, limitations, and healthcare access: Correspondence to editorial on “Antiviral therapy for chronic hepatitis B with mildly elevated aminotransferase: A rollover study from the TORCH-B trial”Chi-Yi Chen, Jaw-Town Lin, Yao-Chun Hsu대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”Gi-Ae Kim, Seung Won Choi, Young-Suk Lim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Correspondence to editorial 1 on “Impacts of metabol ic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues”Mindie H. Nguyen, Rui Huang대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133